Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Minority Interest (2016 - 2025)

Lexaria Bioscience's Minority Interest history spans 10 years, with the latest figure at -$389438.0 for Q4 2025.

  • For Q4 2025, Minority Interest fell 2.41% year-over-year to -$389438.0; the TTM value through Nov 2025 reached -$389438.0, down 2.41%, while the annual FY2025 figure was -$386942.0, 2.54% down from the prior year.
  • Minority Interest for Q4 2025 was -$389438.0 at Lexaria Bioscience, down from -$386942.0 in the prior quarter.
  • Across five years, Minority Interest topped out at -$67957.0 in Q1 2021 and bottomed at -$389438.0 in Q4 2025.
  • The 5-year median for Minority Interest is -$359192.0 (2023), against an average of -$309735.8.
  • The largest annual shift saw Minority Interest crashed 661.52% in 2021 before it fell 2.41% in 2025.
  • A 5-year view of Minority Interest shows it stood at -$212410.0 in 2021, then crashed by 55.25% to -$329776.0 in 2022, then decreased by 12.12% to -$369755.0 in 2023, then dropped by 2.85% to -$380278.0 in 2024, then decreased by 2.41% to -$389438.0 in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Minority Interest are -$389438.0 (Q4 2025), -$386942.0 (Q3 2025), and -$385552.0 (Q2 2025).